Skip to main content
Erschienen in: Rheumatology International 4/2018

15.12.2017 | Observational Research

Patient and physician perspectives on the impact of health-related quality of life in Mexican patients with ANCA-associated vasculitis

verfasst von: Andrea Hinojosa-Azaola, Ariadna Jiménez-González, Natasha Alcocer-Castillejos

Erschienen in: Rheumatology International | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study is to describe aspects of health-related quality of life (HRQOL) in Mexican patients with antineutrophil cytoplasmic-associated vasculitis (AAV). Cross-sectional comparison study includes patients with established AAV and a comparison group with rheumatoid arthritis (RA), chronic kidney disease (CKD), and healthy subjects. Variables considered were: socio-demographic data, comorbidities, laboratory, disease activity, damage, and Physician’s and Patient’s Global Assessment (PhGA and PtGA). The following measurements were done: Pittsburg sleep quality index, Multidimesional Fatigue Inventory (MFI-20), Hospital Anxiety and Depression Scale, Short Form 36 questionnaire (SF-36), and Health Assessment Questionnaire. 60 patients with AAV were included, median age 54 years, and 60% female. Significant differences were found only in the bodily pain domain of the SF-36 (p = 0.01). Aspects of disease relevant for AAV patients were: fatigue and lack of energy; visual abnormalities; neuropathy; renal impairment; arthritis, and sinusitis. Greater total score on MFI-20 (p < 0.001) and worse PtGA (p = 0.01) were associated with worse physical health. Higher PhGA values were associated with worse physical quality of life (p = 0.01). Greater fatigue score (p = 0.002), greater anxiety-depression score (p = 0.005), and worse PtGA (p = 0.01) were associated with worse mental health quality of life. No differences were found in prevalence of sleep impairment, anxiety, depression, or disability between groups. AAV patients experienced more general and physical fatigue (p < 0.0001), and reduced activity (p = 0.01) than healthy subjects, but similar to RA and CKD patients. Vasculitis has negative effects on patients’ physical and mental HRQOL.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Walsh M, Mukhtyar C, Mahr A et al (2011) Health related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Care Res (Hoboken) 63:1055–1061CrossRef Walsh M, Mukhtyar C, Mahr A et al (2011) Health related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Care Res (Hoboken) 63:1055–1061CrossRef
2.
Zurück zum Zitat Basu N, Jones GT, Fluck N et al (2010) Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis. Rheumatology 49:1383–1390CrossRefPubMedPubMedCentral Basu N, Jones GT, Fluck N et al (2010) Fatigue: a principal contributor to impaired quality of life in ANCA-associated vasculitis. Rheumatology 49:1383–1390CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Herlyn K, Hellmich B, Seo P, Merkel PA (2010) Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective. Arthritis Care Res (Hoboken) 62:1639–1645CrossRef Herlyn K, Hellmich B, Seo P, Merkel PA (2010) Patient-reported outcome assessment in vasculitis may provide important data and a unique perspective. Arthritis Care Res (Hoboken) 62:1639–1645CrossRef
5.
Zurück zum Zitat Merkel PA, Aydin SZ, Boers M et al (2011) The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis. J Rheumatol 38:1480–1486CrossRefPubMedPubMedCentral Merkel PA, Aydin SZ, Boers M et al (2011) The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis. J Rheumatol 38:1480–1486CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat McClean A, Morgan MD, Basu N et al (2016) Physical fatigue, fitness, and muscle function in patients with antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Care Res (Hoboken) 68:1332–1339CrossRef McClean A, Morgan MD, Basu N et al (2016) Physical fatigue, fitness, and muscle function in patients with antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Care Res (Hoboken) 68:1332–1339CrossRef
7.
Zurück zum Zitat Brezinova P, Englbrecht M, Lovric S et al (2013) Coping strategies and depressiveness in primary systemic vasculitis—what is their impact on health-related quality of life? Rheumatology 52:1856–1864CrossRefPubMed Brezinova P, Englbrecht M, Lovric S et al (2013) Coping strategies and depressiveness in primary systemic vasculitis—what is their impact on health-related quality of life? Rheumatology 52:1856–1864CrossRefPubMed
8.
Zurück zum Zitat Carpenter DM, Thorpe CT, Lewis M et al (2009) Health-related quality of life for patients with vasculitis and their spouses. Arthritis Care Res (Hoboken) 61:259–265CrossRef Carpenter DM, Thorpe CT, Lewis M et al (2009) Health-related quality of life for patients with vasculitis and their spouses. Arthritis Care Res (Hoboken) 61:259–265CrossRef
9.
Zurück zum Zitat Carpenter DM, Meador AE, Elstad EA et al (2012) The impact of vasculitis on patients’ social participation and friendships. Clin Exp Rheumatol 30:S15-S21PubMedCentral Carpenter DM, Meador AE, Elstad EA et al (2012) The impact of vasculitis on patients’ social participation and friendships. Clin Exp Rheumatol 30:S15-S21PubMedCentral
10.
Zurück zum Zitat Tomasson G, Boers M, Walsh M et al (2012) Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener’s). Arthritis Care Res (Hoboken) 64:273–279CrossRef Tomasson G, Boers M, Walsh M et al (2012) Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener’s). Arthritis Care Res (Hoboken) 64:273–279CrossRef
11.
Zurück zum Zitat Trieste L, Palla I, Baldini C et al (2012) Systemic vasculitis: how little we know about their societal and economic burden. Clin Exp Rheumatol 30:S154-S156 Trieste L, Palla I, Baldini C et al (2012) Systemic vasculitis: how little we know about their societal and economic burden. Clin Exp Rheumatol 30:S154-S156
12.
Zurück zum Zitat Instituto Nacional de Estadística y Geografía (INEGI) (2017) Estadísticas a propósito del Día Mundial de la Justicia Social, Boletín Informativo. http://www.inegi.org.mx. Accessed 17 Feb 2017 Instituto Nacional de Estadística y Geografía (INEGI) (2017) Estadísticas a propósito del Día Mundial de la Justicia Social, Boletín Informativo. http://​www.​inegi.​org.​mx. Accessed 17 Feb 2017
13.
Zurück zum Zitat Flossmann O (2015) Risks of treatments and long-term outcomes of systemic ANCA-associated vasculitis. Presse Med 44:e251–e257CrossRefPubMed Flossmann O (2015) Risks of treatments and long-term outcomes of systemic ANCA-associated vasculitis. Presse Med 44:e251–e257CrossRefPubMed
14.
Zurück zum Zitat Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11CrossRefPubMed Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11CrossRefPubMed
15.
Zurück zum Zitat Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107CrossRefPubMed Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum 33:1101–1107CrossRefPubMed
16.
Zurück zum Zitat Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid Arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581CrossRefPubMed Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid Arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569–2581CrossRefPubMed
17.
Zurück zum Zitat Levin A, Stevens PE (2014) Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 85:49–61CrossRefPubMed Levin A, Stevens PE (2014) Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 85:49–61CrossRefPubMed
18.
Zurück zum Zitat Basu N, McClean A, Harper L et al (2014) The characterisation and determinants of quality of life in ANCA associated vasculitis. Ann Rheum Dis 73:207–211CrossRefPubMed Basu N, McClean A, Harper L et al (2014) The characterisation and determinants of quality of life in ANCA associated vasculitis. Ann Rheum Dis 73:207–211CrossRefPubMed
19.
Zurück zum Zitat Stone JH, Hoffman GS, Merkel PA et al (2001) A disease specific activity index for Wegener’s granulomatosis: Modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 44:912–920CrossRefPubMed Stone JH, Hoffman GS, Merkel PA et al (2001) A disease specific activity index for Wegener’s granulomatosis: Modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 44:912–920CrossRefPubMed
20.
Zurück zum Zitat Exley AR, Bacon PA, Luqmani RA et al (1997) Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 40:371–380CrossRefPubMed Exley AR, Bacon PA, Luqmani RA et al (1997) Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 40:371–380CrossRefPubMed
21.
Zurück zum Zitat Buysse DJ, Reynolds CF, Monk TH et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213CrossRefPubMed Buysse DJ, Reynolds CF, Monk TH et al (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213CrossRefPubMed
22.
Zurück zum Zitat Mollayeva T, Thurairajah P, Burton K et al (2016) The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis. Sleep Med Rev 25:52–73CrossRefPubMed Mollayeva T, Thurairajah P, Burton K et al (2016) The Pittsburgh sleep quality index as a screening tool for sleep dysfunction in clinical and non-clinical samples: a systematic review and meta-analysis. Sleep Med Rev 25:52–73CrossRefPubMed
23.
Zurück zum Zitat Boada-Grau J, Merino-Tejedor E, Gil-Ripoll C et al (2014) Adaptación al español del Inventario Multidimensional de Fatiga al entorno laboral. Univ Psychol 13:15–23 Boada-Grau J, Merino-Tejedor E, Gil-Ripoll C et al (2014) Adaptación al español del Inventario Multidimensional de Fatiga al entorno laboral. Univ Psychol 13:15–23
24.
Zurück zum Zitat Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 52:69–77CrossRefPubMed Bjelland I, Dahl AA, Haug TT, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 52:69–77CrossRefPubMed
25.
Zurück zum Zitat Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed Zigmond AS, Snaith RP (1983) The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361–370CrossRefPubMed
26.
Zurück zum Zitat Ponte C, Sznajd J, O’Neill L, Luqmani R (2014) Optimisation of vasculitis disease assessments in clinical trials, clinical care and long-term databases. Clin Exp Rheumatol 32(sup 85):S118–S125 Ponte C, Sznajd J, O’Neill L, Luqmani R (2014) Optimisation of vasculitis disease assessments in clinical trials, clinical care and long-term databases. Clin Exp Rheumatol 32(sup 85):S118–S125
27.
Zurück zum Zitat Maruish ME (2011) User’s Manual for the SF-36v2 Health Survey, 3rd edn. QualityMetric Incorporated, Lincoln Maruish ME (2011) User’s Manual for the SF-36v2 Health Survey, 3rd edn. QualityMetric Incorporated, Lincoln
28.
Zurück zum Zitat Bruce B, Fries JF (2003) The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 30:167–178PubMed Bruce B, Fries JF (2003) The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 30:167–178PubMed
29.
Zurück zum Zitat González V, Stewart A, Ritter P, Lorig K (1995) Translation and validation of arthritis outcome measures into Spanish. Arthritis Rheum 38:1429–1446CrossRefPubMed González V, Stewart A, Ritter P, Lorig K (1995) Translation and validation of arthritis outcome measures into Spanish. Arthritis Rheum 38:1429–1446CrossRefPubMed
30.
Zurück zum Zitat Zúniga MA, Carrillo-Jiménez GT, Fos PJ et al (1999) Evaluación del estado de salud con la Encuesta SF-36: resultados preliminares en México. Salud Publica Mex 41:110–118CrossRefPubMed Zúniga MA, Carrillo-Jiménez GT, Fos PJ et al (1999) Evaluación del estado de salud con la Encuesta SF-36: resultados preliminares en México. Salud Publica Mex 41:110–118CrossRefPubMed
31.
Zurück zum Zitat López-Alvarenga JC, Vázquez-Velázquez V, Arcila-Martínez D (2002) Accuracy and diagnostic utility of the Hospital Anxiety and Depression Scale (HAD) in a sample of obese Mexican patients. Rev Invest Clin 54:403–409PubMed López-Alvarenga JC, Vázquez-Velázquez V, Arcila-Martínez D (2002) Accuracy and diagnostic utility of the Hospital Anxiety and Depression Scale (HAD) in a sample of obese Mexican patients. Rev Invest Clin 54:403–409PubMed
32.
Zurück zum Zitat Escobar-Córdoba F, Eslava-Schmalbach J (2005) Colombian validation of the Pittsburgh Sleep Quality Index. Rev Neurol 40:150–155PubMed Escobar-Córdoba F, Eslava-Schmalbach J (2005) Colombian validation of the Pittsburgh Sleep Quality Index. Rev Neurol 40:150–155PubMed
33.
Zurück zum Zitat Durán-Arenas l, Gallegos-Carrillo K, Salinas-Escudero G et al (2004) Hacia una base normativa Mexicana en la medición de calidad de vida relacionada con la salud, mediante el Formato Corto 36. Salud Publica Mex 46:306–315CrossRefPubMed Durán-Arenas l, Gallegos-Carrillo K, Salinas-Escudero G et al (2004) Hacia una base normativa Mexicana en la medición de calidad de vida relacionada con la salud, mediante el Formato Corto 36. Salud Publica Mex 46:306–315CrossRefPubMed
34.
Zurück zum Zitat Acock AC (2012) A Gentle Introduction to Stata, 3rd edn. Stata Press, Texas Acock AC (2012) A Gentle Introduction to Stata, 3rd edn. Stata Press, Texas
35.
Zurück zum Zitat Basu N, McClean A, Harper L et al (2013) Explaining fatigue in ANCA-associated vasculitis. Rheumatology 52:1680–1685CrossRefPubMed Basu N, McClean A, Harper L et al (2013) Explaining fatigue in ANCA-associated vasculitis. Rheumatology 52:1680–1685CrossRefPubMed
36.
Zurück zum Zitat Basu N, McClean A, Harper L et al (2014) Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology 53:953–956CrossRefPubMed Basu N, McClean A, Harper L et al (2014) Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology 53:953–956CrossRefPubMed
37.
Zurück zum Zitat Novakovich E, Grayson PC (2015) What matters for patients with vasculitis? Presse Med 44:e267–e272CrossRefPubMed Novakovich E, Grayson PC (2015) What matters for patients with vasculitis? Presse Med 44:e267–e272CrossRefPubMed
38.
Zurück zum Zitat Basu N, Murray AD, Jones GT et al (2014) Neural correlates of fatigue in granulomatosis with polyangiitis: a functional magnetic resonance imaging study. Rheumatology 53:2080–2087CrossRefPubMed Basu N, Murray AD, Jones GT et al (2014) Neural correlates of fatigue in granulomatosis with polyangiitis: a functional magnetic resonance imaging study. Rheumatology 53:2080–2087CrossRefPubMed
39.
Zurück zum Zitat Carpenter DM, Kadis JA, Devellis RF et al (2011) The effect of medication-related support on the quality of life of patients with vasculitis in relapse and remission. J Rheumatol 38:709–715CrossRefPubMedPubMedCentral Carpenter DM, Kadis JA, Devellis RF et al (2011) The effect of medication-related support on the quality of life of patients with vasculitis in relapse and remission. J Rheumatol 38:709–715CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Tomasson G (2013) Quality of life and outcome measures in vasculitis. Best Pract Res Clin Rheumatol 27:69–77CrossRefPubMed Tomasson G (2013) Quality of life and outcome measures in vasculitis. Best Pract Res Clin Rheumatol 27:69–77CrossRefPubMed
41.
Zurück zum Zitat van Tuyl LH, Boers M (2012) Patient’s global assessment of disease activity: what are we measuring? Arthritis Rheum 64:2811–2813CrossRefPubMed van Tuyl LH, Boers M (2012) Patient’s global assessment of disease activity: what are we measuring? Arthritis Rheum 64:2811–2813CrossRefPubMed
42.
Zurück zum Zitat Jolly M, Kosinski M, Garris CP, Oglesby AK (2016) Prospective validation of the lupus impact tracker: a patient-completed tool for clinical practice to evaluate the impact of systemic lupus erythematosus. Arthritis Rheumatol 68:1422–1431CrossRefPubMed Jolly M, Kosinski M, Garris CP, Oglesby AK (2016) Prospective validation of the lupus impact tracker: a patient-completed tool for clinical practice to evaluate the impact of systemic lupus erythematosus. Arthritis Rheumatol 68:1422–1431CrossRefPubMed
43.
Zurück zum Zitat Milman N, Boonen A, Tugwell P, Merkel P (2017) Clinicians’ perspective on key domains in ANCA-associated vasculitis: a Delphi exercise. Scand J Rheumatol 46:112–117CrossRefPubMed Milman N, Boonen A, Tugwell P, Merkel P (2017) Clinicians’ perspective on key domains in ANCA-associated vasculitis: a Delphi exercise. Scand J Rheumatol 46:112–117CrossRefPubMed
44.
Zurück zum Zitat Robson JC, Milman N, Tomasson G et al (2015) Exploration, development, and validation of patient-reported outcomes in antineutrophil cytoplasmic antibody–associated vasculitis using the OMERACT process. J Rheumatol 42:2204–2209CrossRefPubMedPubMedCentral Robson JC, Milman N, Tomasson G et al (2015) Exploration, development, and validation of patient-reported outcomes in antineutrophil cytoplasmic antibody–associated vasculitis using the OMERACT process. J Rheumatol 42:2204–2209CrossRefPubMedPubMedCentral
Metadaten
Titel
Patient and physician perspectives on the impact of health-related quality of life in Mexican patients with ANCA-associated vasculitis
verfasst von
Andrea Hinojosa-Azaola
Ariadna Jiménez-González
Natasha Alcocer-Castillejos
Publikationsdatum
15.12.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 4/2018
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-017-3904-1

Weitere Artikel der Ausgabe 4/2018

Rheumatology International 4/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.